Oura valued at $5B following deal with medical device firm Dexcom
Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.
360dx2m
'On Vivo' and 'In Vivo' Wearable Diagnostics Advancing to Clinical Use
NEW YORK – By transforming disease detection and monitoring from static data ... leading CGM manufacturers, along with Dexcom, Medtronic, and Eversense, that use needle‐based enzyme electrodes to ...